info icon

This is a non-core endpoint: only basic statistics are computed.

Melanoma in situ of lower limb, including hip (controls excluding all cancers)

CD2_INSITU_MELANOMA_LOWERLIMB_EXALLC

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D03.7&
Cause of death: ICD-10 D03.7&

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

133

diagram downward connector
CD2_INSITU_MELANOMA_LOWERLIMB_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D03
Name in latin Melanoma in situ coxae

Summary Statistics

Key figures

All Female Male
Number of individuals 133 99 34
Unadjusted prevalence (%) 0.04 0.05 0.02
Mean age at first event (years) 62.00 60.83 65.42

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: CD2_INSITU_MELANOMA_LOWERLIMB_EXALLC – Melanoma in situ of lower limb, including hip (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Melanoma in situ of lower limb, including hip (controls excluding all cancers)

Endpoint not on priority list, no data to show.